OpenURL Connection Search

Select item for more details and to access through your institution.

A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma.
Published in:
Clinical Genitourinary Cancer, 2021, v. 19, n. 5, p. 434, doi. 10.1016/j.clgc.2021.04.007
By:
- Chowdhury, Simon;
- Infante, Jeffery R.;
- Hawkins, Robert;
- Voss, Martin H.;
- Perini, Rodolfo;
- Arkenau, Tobias;
- Voskoboynik, Mark;
- Aimone, Paola;
- Naeije, Isabelle;
- Reising, Albert;
- McDermott, David F.
Publication type:
Article
The role of surveillance imaging for resected high‐risk melanoma.
Published in:
Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 4, p. 566, doi. 10.1111/ajco.13913
By:
- Yan, Mabel K.;
- Adler, Nikki R.;
- Wolfe, Rory;
- Pan, Yan;
- Chamberlain, Alexander;
- Kelly, John;
- Yap, Kenneth;
- Voskoboynik, Mark;
- Haydon, Andrew;
- Shackleton, Mark;
- Mar, Victoria J.
Publication type:
Article
Improving regional access: Phase 1 teletrials in the era of COVID‐19.
Published in:
Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 4, p. 416, doi. 10.1111/ajco.13558
By:
- Gaughran, Gregory;
- Zalcberg, John;
- Hawkins, Cheryl‐Ann;
- Shackleton, Mark;
- Voskoboynik, Mark
Publication type:
Article
Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC.
Published in:
Clinical Lung Cancer, 2021, v. 22, n. 3, p. e425, doi. 10.1016/j.cllc.2020.06.001
By:
- Samuel, Evangeline;
- Lie, Gabrielle;
- Balasubramanian, Adithya;
- Hiong, Alison;
- So, Yeojeong;
- Voskoboynik, Mark;
- Moore, Maggie;
- Shackleton, Mark;
- Haydon, Andrew;
- John, Tom;
- Mitchell, Paul L.R.;
- Markman, Ben;
- Briggs, Peter;
- Parakh, Sagun
Publication type:
Article
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial.
Published in:
Cancers, 2022, v. 14, n. 17, p. 4079, doi. 10.3390/cancers14174079
By:
- Hilton, John;
- Cristea, Mihaela;
- Postel-Vinay, Sophie;
- Baldini, Capucine;
- Voskoboynik, Mark;
- Edenfield, William;
- Shapiro, Geoffrey I.;
- Cheng, Michael L.;
- Vuky, Jacqueline;
- Corr, Bradley;
- Das, Sharmila;
- Apfel, Abraham;
- Xu, Ke;
- Kozicki, Martin;
- Ünsal-Kaçmaz, Keziban;
- Hammell, Amy;
- Wang, Guan;
- Ravindran, Palanikumar;
- Kollia, Georgia;
- Esposito, Oriana
Publication type:
Article
SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.
Published in:
2017
By:
- Greystoke, Alastair;
- Steele, Nicola;
- Arkenau, Hendrik-Tobias;
- Blackhall, Fiona;
- Md Haris, Noor;
- Lindsay, Colin R;
- Califano, Raffaele;
- Voskoboynik, Mark;
- Summers, Yvonne;
- So, Karen;
- Ghiorghiu, Dana;
- Dymond, Angela W;
- Hossack, Stuart;
- Plummer, Ruth;
- Dean, Emma
Publication type:
journal article
Yield of baseline imaging for distant metastases in high‐risk primary melanoma.
Published in:
Journal of Surgical Oncology, 2022, v. 125, n. 8, p. 1312, doi. 10.1002/jso.26846
By:
- Yan, Mabel K.;
- Adler, Nikki R.;
- Pan, Yan;
- Chamberlain, Alexander;
- Kelly, John;
- Yap, Kenneth;
- Voskoboynik, Mark;
- Haydon, Andrew;
- Shackleton, Mark;
- Mar, Victoria J.
Publication type:
Article
Immunotherapy for bladder cancer: rediscovering an old friend.
Published in:
BJU International, 2016, v. 117, n. 5, p. 721, doi. 10.1111/bju.13330
By:
- Voskoboynik, Mark;
- Rudman, Sarah;
- Arkenau, Hendrik‐Tobias;
- Hughes, Simon;
- Chowdhury, Simon
Publication type:
Article
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia.
Published in:
Drug Design, Development & Therapy, 2020, v. 14, p. 1177, doi. 10.2147/DDDT.S243787
By:
- Lickliter, Jason D;
- Gan, Hui K;
- Voskoboynik, Mark;
- Arulananda, Surein;
- Gao, Bo;
- Nagrial, Adnan;
- Grimison, Peter;
- Harrison, Michelle;
- Zou, Jianjun;
- Zhang, Lianshan;
- Luo, Stacey;
- Lahn, Michael;
- Kallender, Howard;
- Mannucci, Andrea;
- Somma, Catello;
- Woods, Katherine;
- Behren, Andreas;
- Fernandez-Penas, Pablo;
- Millward, Michael;
- Meniawy, Tarek
Publication type:
Article
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours.
Published in:
British Journal of Cancer, 2023, v. 128, n. 8, p. 1418, doi. 10.1038/s41416-022-02128-3
By:
- Desai, Jayesh;
- Fong, Peter;
- Moreno, Victor;
- Frentzas, Sophia;
- Meniawy, Tarek;
- Markman, Ben;
- Voskoboynik, Mark;
- Rahman, Tahmina;
- Budha, Nageshwar;
- Wu, John;
- Marlow, Jin;
- Yang, Silu;
- Calvo, Emiliano;
- Martin-Liberal, Juan
Publication type:
Article
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.
Published in:
2022
By:
- Lickliter, Jason D.;
- Voskoboynik, Mark;
- Mileshkin, Linda;
- Gan, Hui K.;
- Kichenadasse, Ganessan;
- Zhang, Kathy;
- Zhang, Maggie;
- Tang, Zhiyu;
- Millward, Michael
Publication type:
journal article
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.
Published in:
2022
By:
- Lickliter, Jason D.;
- Voskoboynik, Mark;
- Mileshkin, Linda;
- Gan, Hui K.;
- Kichenadasse, Ganessan;
- Zhang, Kathy;
- Zhang, Maggie;
- Tang, Zhiyu;
- Millward, Michael
Publication type:
corrected article
Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study.
Published in:
Cardio-Oncology, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40959-022-00149-8
By:
- Wang, Charlie;
- Zoungas, Sophia;
- Yan, Mabel;
- Wolfe, Rory;
- Haydon, Andrew;
- Shackleton, Mark;
- Voskoboynik, Mark;
- Moore, Maggie;
- Andrews, Miles C.;
- Nicholls, Stephen J.;
- Mar, Victoria
Publication type:
Article
Immune-related adverse events secondary to immunotherapy in oncology.
Published in:
Australian Journal of General Practice, 2023, v. 52, n. 6, p. 378, doi. 10.31128/ajgp-04-22-6408
By:
- Hui-Ling Yeoh;
- Freilich, Karen;
- Voskoboynik, Mark;
- Moore, Maggie;
- Andrews, Miles C.;
- Shackleton, Mark;
- Haydon, Andrew M.
Publication type:
Article
Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence.
Published in:
Biochemistry Research International, 2014, p. 1, doi. 10.1155/2014/307059
By:
- Voskoboynik, Mark;
- Arkenau, Hendrik-Tobias
Publication type:
Article
Clinicopathological characteristics associated with BRAF<sup>K601E</sup> and BRAF<sup>L597</sup> mutations in melanoma.
Published in:
Pigment Cell & Melanoma Research, 2016, v. 29, n. 2, p. 222, doi. 10.1111/pcmr.12450
By:
- Voskoboynik, Mark;
- Mar, Victoria;
- Mailer, Sonia;
- Colebatch, Andrew;
- Fennessy, Anne;
- Logan, Aleksandra;
- Hewitt, Chelsee;
- Cebon, Jonathon;
- Kelly, John;
- McArthur, Grant
Publication type:
Article
A phase 1 dose‐escalation study of the poly(ADP‐ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors.
Published in:
Cancer (0008543X), 2023, v. 129, n. 7, p. 1041, doi. 10.1002/cncr.34662
By:
- Gao, Bo;
- Voskoboynik, Mark;
- Cooper, Adam;
- Wilkinson, Kate;
- Hoon, Siao;
- Hsieh, Chih‐Yi;
- Cai, Suixiong;
- Tian, Ye Edward;
- Bao, Jun;
- Ma, Ning;
- Wang, Chen;
- Zhang, Ming;
- Li, Baoyue;
- Guo, Mingchuan;
- Zhou, Ruiyu;
- Wang, Xiaozhu;
- Xu, Cong;
- de Souza, Paul
Publication type:
Article
First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors.
Published in:
Cancer (0008543X), 2020, v. 126, n. 22, p. 4926, doi. 10.1002/cncr.33133
By:
- Geva, Ravit;
- Voskoboynik, Mark;
- Dobrenkov, Konstantin;
- Mayawala, Kapil;
- Gwo, Jennifer;
- Wnek, Richard;
- Chartash, Elliot;
- Long, Georgina V.
Publication type:
Article

Found: 18